508
Views
4
CrossRef citations to date
0
Altmetric
Invited Viewpoint

Fluoroquinolones are a potent form of chemotherapy

, PhD BAppSc (Optom) (Hons) GradCertEd (Higher Ed) GradCertOcThera SFHEA
Pages 412-416 | Received 26 Mar 2020, Accepted 06 May 2020, Published online: 15 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sara Badawy, YaQin Yang, Yanan Liu, Marawan A. Marawan, Irma Ares, María-Aránzazu Martinez, María-Rosa Martínez-Larrañaga, Xu Wang, Arturo Anadón & Marta Martínez. (2021) Toxicity induced by ciprofloxacin and enrofloxacin: oxidative stress and metabolism. Critical Reviews in Toxicology 51:9, pages 754-787.
Read now
Alex Hui & Isabelle Jalbert. (2021) Ocular therapeutics: from special interest to standard care. Clinical and Experimental Optometry 104:3, pages 265-266.
Read now

Articles from other publishers (2)

Yusu Wang. 2023. Cases on Teaching Pharmacology to Complementary and Alternative Medicine Students. Cases on Teaching Pharmacology to Complementary and Alternative Medicine Students 104 115 .
Essmat M. El-Sheref, Hendawy N. Tawfeek, Alaa A. Hassan, S. Bräse, Mohammed A. I. Elbastawesy, Hesham A. M. Gomaa, Yaser A. Mostafa & Bahaa G. M. Youssif. (2022) Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties. Frontiers in Chemistry 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.